MAXIMUS, Inc. (NYSE:MMS) Expected to Post Quarterly Sales of $756.84 Million

Equities research analysts predict that MAXIMUS, Inc. (NYSE:MMS) will announce $756.84 million in sales for the current quarter, Zacks Investment Research reports. Four analysts have made estimates for MAXIMUS’s earnings, with estimates ranging from $751.01 million to $762.19 million. MAXIMUS posted sales of $597.86 million during the same quarter last year, which suggests a positive year over year growth rate of 26.6%. The company is scheduled to announce its next earnings report on Thursday, August 8th.

According to Zacks, analysts expect that MAXIMUS will report full-year sales of $2.93 billion for the current fiscal year, with estimates ranging from $2.92 billion to $2.94 billion. For the next fiscal year, analysts forecast that the business will report sales of $3.20 billion, with estimates ranging from $3.12 billion to $3.24 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research analysts that follow MAXIMUS.

MAXIMUS (NYSE:MMS) last posted its quarterly earnings results on Thursday, May 9th. The health services provider reported $0.96 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.91 by $0.05. MAXIMUS had a net margin of 8.76% and a return on equity of 21.19%. The firm had revenue of $736.50 million during the quarter, compared to the consensus estimate of $757.29 million. During the same quarter in the previous year, the firm posted $0.84 earnings per share. The company’s revenue was up 20.2% on a year-over-year basis.

Several analysts have recently weighed in on MMS shares. Zacks Investment Research raised shares of MAXIMUS from a “hold” rating to a “buy” rating and set a $78.00 price target for the company in a research note on Tuesday, February 12th. ValuEngine downgraded shares of MAXIMUS from a “buy” rating to a “hold” rating in a research note on Thursday, February 28th.

In related news, Vice Chairman Richard A. Montoni sold 35,000 shares of the business’s stock in a transaction that occurred on Thursday, March 14th. The shares were sold at an average price of $70.97, for a total value of $2,483,950.00. Following the completion of the transaction, the insider now owns 412,874 shares of the company’s stock, valued at $29,301,667.78. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Russell A. Beliveau sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $71.40, for a total transaction of $71,400.00. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.

A number of large investors have recently modified their holdings of MMS. Oregon Public Employees Retirement Fund raised its stake in MAXIMUS by 6,329.9% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 1,656,085 shares of the health services provider’s stock worth $25,000 after buying an additional 1,630,329 shares in the last quarter. Norges Bank bought a new position in MAXIMUS in the fourth quarter worth approximately $49,088,000. Skandinaviska Enskilda Banken AB publ raised its stake in MAXIMUS by 54.5% in the first quarter. Skandinaviska Enskilda Banken AB publ now owns 957,446 shares of the health services provider’s stock worth $67,960,000 after buying an additional 337,897 shares in the last quarter. Vaughan Nelson Investment Management L.P. bought a new position in MAXIMUS in the first quarter worth approximately $23,766,000. Finally, Virginia Retirement Systems ET AL grew its holdings in MAXIMUS by 1,483.2% in the first quarter. Virginia Retirement Systems ET AL now owns 310,300 shares of the health services provider’s stock worth $22,025,000 after purchasing an additional 290,700 shares during the last quarter. 94.37% of the stock is owned by institutional investors.

MAXIMUS stock opened at $74.56 on Wednesday. The company has a quick ratio of 2.31, a current ratio of 2.31 and a debt-to-equity ratio of 0.06. MAXIMUS has a fifty-two week low of $60.00 and a fifty-two week high of $75.48. The company has a market cap of $4.77 billion, a PE ratio of 21.93, a P/E/G ratio of 2.02 and a beta of 0.92.

The business also recently declared a quarterly dividend, which was paid on Friday, May 31st. Stockholders of record on Wednesday, May 15th were paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 1.34%. The ex-dividend date was Tuesday, May 14th. MAXIMUS’s dividend payout ratio is presently 29.41%.

About MAXIMUS

MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.

Read More: When can a hold rating present a buying opportunity?

Get a free copy of the Zacks research report on MAXIMUS (MMS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit